Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 27566200)

  • 1. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
    Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
    J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3/miR-214 signaling pathway.
    Chen X; Xu T; Lv X; Zhang J; Liu S
    J Ethnopharmacol; 2021 Jun; 274():113997. PubMed ID: 33705918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.
    Liu J; Shimizu K; Yu H; Zhang C; Jin F; Kondo R
    Fitoterapia; 2010 Oct; 81(7):902-5. PubMed ID: 20554003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism.
    Liu GW; Liu YH; Jiang GS; Ren WD
    Hum Cell; 2018 Jul; 31(3):189-198. PubMed ID: 29582366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sesamolin exerts anti-proliferative and apoptotic effect on human colorectal cancer cells via inhibition of JAK2/STAT3 signaling pathway.
    Wu D; Wang XP; Zhang W
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):96-100. PubMed ID: 31472054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
    Lv Q; Rong N; Liu LJ; Xu XL; Liu JT; Jin FX; Wang CM
    Planta Med; 2016 May; 82(8):705-11. PubMed ID: 27163230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer property of ginsenoside Rh2 from ginseng.
    Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
    Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
    Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
    World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
    Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
    Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
    Yuan Y; Wang J; Xu M; Zhang Y; Wang Z; Liang L; Sun P
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside Rh3 Inhibits Proliferation and Induces Apoptosis of Colorectal Cancer Cells.
    Cong Z; Zhao Q; Yang B; Cong D; Zhou Y; Lei X; Zhang X
    Pharmacology; 2020; 105(5-6):329-338. PubMed ID: 31671429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
    Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
    Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
    Zhang ZH; Li MY; Wang Z; Zuo HX; Wang JY; Xing Y; Jin C; Xu G; Piao L; Piao H; Ma J; Jin X
    Phytomedicine; 2020 Mar; 68():153172. PubMed ID: 32004989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway.
    Liu X; Ji Q; Ye N; Sui H; Zhou L; Zhu H; Fan Z; Cai J; Li Q
    PLoS One; 2015; 10(5):e0123478. PubMed ID: 25954974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future.
    Guan W; Qi W
    Phytomedicine; 2023 Sep; 118():154938. PubMed ID: 37406390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis.
    Gao H; Liang D; Li C; Xu G; Jiang M; Li H; Yin J; Song Y
    Biomed Pharmacother; 2020 Apr; 124():109891. PubMed ID: 31991384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells.
    Joo MK; Park JJ; Kim SH; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
    Int J Oncol; 2015; 46(6):2380-8. PubMed ID: 25815436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARδ-STAT3 Signaling in Type 1-Like Diabetic Rats.
    Lo SH; Hsu CT; Niu HS; Niu CS; Cheng JT; Chen ZC
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28672855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer.
    Zhang H; Zhao B; Wei H; Zeng H; Sheng D; Zhang Y
    J Ethnopharmacol; 2022 Apr; 287():114915. PubMed ID: 34954267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review).
    Zhang H; Park S; Huang H; Kim E; Yi J; Choi SK; Ryoo Z; Kim M
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.